{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:45:35Z","timestamp":1793659535552,"version":"4.5.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014935","name":"BioCryst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014935","name":"BioCryst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaip.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T02:05:30Z","timestamp":1585879530000},"page":"1875-1880.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review"],"prefix":"10.1016","volume":"8","author":[{"given":"Joel P.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Radojicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Newcomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Ida","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.03.009_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.03.009_bib2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.009_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2009.12.004","article-title":"Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?","volume":"104","author":"Lunn","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.anai.2013.08.019","article-title":"The burden of illness in patients with hereditary angioedema","volume":"111","author":"Banerji","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib5","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaip.2018.11.042","article-title":"Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States","volume":"7","author":"Busse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.03.009_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1710-1492-6-17","article-title":"Hereditary angioedema in women","volume":"6","author":"Bouillet","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2020.03.009_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1710-1492-6-16","article-title":"Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions","volume":"6","author":"Binkley","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000368404","article-title":"Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting","volume":"165","author":"Craig","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.11.025","article-title":"International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency","volume":"129","author":"Caballero","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.iac.2013.07.006","article-title":"Hereditary angioedema in women: specific challenges","volume":"33","author":"Bouillet","year":"2013","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2020.03.009_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2500\/aap.2013.34.3635","article-title":"HAE update: special considerations in the female patient with hereditary angioedema","volume":"34","author":"Geng","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/IJWH.S46460","article-title":"Management of hereditary angioedema in pregnant women: a review","volume":"6","author":"Caballero","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.jaip.2020.03.009_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2500\/aap.2015.36.3911","article-title":"Hereditary angioedema: special consideration in children, women of childbearing age, and the elderly","volume":"36","author":"Kuhlen","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bib16","first-page":"351","article-title":"Managing the female patient with hereditary angioedema","volume":"12","author":"Banerji","year":"2016","journal-title":"Womens Health"},{"key":"10.1016\/j.jaip.2020.03.009_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2010.05.008","article-title":"The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey","volume":"152","author":"Czaller","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaip.2020.03.009_bib18","doi-asserted-by":"crossref","first-page":"131.e1","DOI":"10.1016\/j.ajog.2010.03.003","article-title":"Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate","volume":"203","author":"Martinez-Saguer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2020.03.009_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.18176\/jiaci.0037","article-title":"Management of pregnancy and delivery in patients with hereditary angioedema due to C1 inhibitor deficiency","volume":"26","author":"Gonzalez-Quevedo","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib20","doi-asserted-by":"crossref","first-page":"484.e1","DOI":"10.1016\/j.ajog.2008.04.034","article-title":"Disease expression in women with hereditary angioedema","volume":"199","author":"Bouillet","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2020.03.009_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejogrb.2012.07.010","article-title":"Successful pregnancy outcome after treatment with C1-inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages","volume":"165","author":"Farkas","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaip.2020.03.009_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2007.06.026","article-title":"Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy","volume":"120","author":"Farkas","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/01443615.2014.925860","article-title":"Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood","volume":"35","author":"Farkas","year":"2015","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.jaip.2020.03.009_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/aap.2013.34.3645","article-title":"Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women","volume":"34","author":"Baker","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2500\/aap.2017.38.4038","article-title":"Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema","volume":"38","author":"Fox","year":"2017","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2169\/internalmedicine.9407-17","article-title":"Comparison of the frequency of angioedema attack, before and during pregnancy, in a patient with type i hereditary angioedema","volume":"57","author":"Satomura","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.jaip.2020.03.009_bib27","doi-asserted-by":"crossref","first-page":"2706751","DOI":"10.1155\/2018\/2706751","article-title":"In\u00a0vitro fertilization using luteinizing hormone-releasing hormone injections resulted in healthy triplets without increased attack rates in a hereditary angioedema case","volume":"2018","author":"Tunakan Dalgic","year":"2018","journal-title":"Case Reports Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1258\/om.2009.090003","article-title":"Hereditary angioedema and pregnancy: successful management of recurrent and frequent attacks of angioedema with C1-inhibitor concentrate, danazol and tranexamic acid\u2014a case report","volume":"2","author":"Milingos","year":"2009","journal-title":"Obstet Med"},{"key":"10.1016\/j.jaip.2020.03.009_bib29","first-page":"447","article-title":"Icatibant exposure during pregnancy in a patient with hereditary angioedema","volume":"25","author":"Zanichelli","year":"2015","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jog.13003","article-title":"First report of icatibant treatment in a pregnant patient with hereditary angioedema","volume":"42","author":"Farkas","year":"2016","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jaip.2020.03.009_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2500\/ar.2017.8.0210","article-title":"Multiple doses of icatibant used during pregnancy","volume":"8","author":"Kaminsky","year":"2017","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.jaip.2020.03.009_bib32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10875-018-0553-4","article-title":"Treatment of hereditary angioedema attacks with icatibant and recombinant C1 inhibitor during pregnancy","volume":"38","author":"Hakl","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bib33","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1016\/j.jaip.2019.05.042","article-title":"Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy","volume":"7","author":"Moldovan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.03.009_bib34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jaip.2019.01.054","article-title":"Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks","volume":"7","author":"Craig","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.03.009_bibE1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10875-018-0553-4","article-title":"Treatment of hereditary angioedema attacks with icatibant and recombinant C1 inhibitor during pregnancy","volume":"38","author":"Hakl","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijoa.2018.07.003","article-title":"Repeated attacks of type III hereditary angioedema with factor XII mutation during pregnancy","volume":"36","author":"Feray","year":"2018","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.jaip.2020.03.009_bibE3","doi-asserted-by":"crossref","first-page":"2706751","DOI":"10.1155\/2018\/2706751","article-title":"In\u00a0vitro fertilization using luteinizing hormone-releasing hormone injections resulted in healthy triplets without increased attack rates in a hereditary angioedema case","volume":"2018","author":"Tunakan Dalgi\u00e7","year":"2018","journal-title":"Case Reports Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaip.2017.12.022","article-title":"Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH","volume":"6","author":"Garcia","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.03.009_bibE5","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(17)32206-7","article-title":"Recurrent ascites: a need to evaluate for hereditary angio-oedema","volume":"390","author":"G\u00e1bos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.03.009_bibE6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2169\/internalmedicine.9407-17","article-title":"Comparison of the frequency of angioedema attack, before and during pregnancy, in a patient with type I hereditary angioedema","volume":"57","author":"Satomura","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.jaip.2020.03.009_bibE7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.anai.2017.08.015","article-title":"Successful perinatal management of hereditary angioedema with normal C1 esterase inhibitor and factor XII mutation using C1 esterase inhibitor therapy","volume":"119","author":"Gibbons","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.alit.2017.05.008","article-title":"Successful long-term prophylaxis with human plasma-derived C1 inhibitor in planning and carrying out pregnancy","volume":"67","author":"Calaforra-Mendez","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2020.03.009_bibE9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.anai.2017.04.001","article-title":"Successful management of hereditary angioedema during pregnancy in a patient with heterozygous MTHFR mutation","volume":"118","author":"Martinez Saguer","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2500\/aap.2017.38.4038","article-title":"Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema","volume":"38","author":"Fox","year":"2017","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bibE11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.18176\/jiaci.0037","article-title":"Management of pregnancy and delivery in patients with hereditary angioedema due to C1 inhibitor deficiency","volume":"26","author":"Gonz\u00e1lez-Quevedo","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jog.13003","article-title":"First report of icatibant treatment in a pregnant patient with hereditary angioedema","volume":"42","author":"Farkas","year":"2016","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jaip.2020.03.009_bibE13","first-page":"447","article-title":"Icatibant exposure during pregnancy in a patient with hereditary angioedema","volume":"25","author":"Zanichelli","year":"2015","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijoa.2014.05.010","article-title":"Caesarean delivery in a parturient with type III hereditary angioedema","volume":"23","author":"Soltanifar","year":"2014","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.jaip.2020.03.009_bibE15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/01443615.2014.925860","article-title":"Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood","volume":"35","author":"Farkas","year":"2015","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/imj.12281","article-title":"Management dilemmas in a case of angioedema with normal C1 inhibitor function during pregnancy","volume":"43","author":"Tran","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaip.2020.03.009_bibE17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/aap.2013.34.3645","article-title":"Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women","volume":"34","author":"Baker","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.009_bibE18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijgo.2012.09.009","article-title":"Management of hereditary angioedema with C1-inhibitor concentrate during two successive pregnancies","volume":"120","author":"Chan","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jaip.2020.03.009_bibE19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","article-title":"Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families","volume":"109","author":"Marcos","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2010.05.008","article-title":"The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey","volume":"152","author":"Czaller","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clim.2010.05.008","article-title":"Management of pregnancy and vaginal delivery by C1 inhibitor concentrate in two hereditary angioedema twins","volume":"136","author":"Montinaro","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE22","doi-asserted-by":"crossref","first-page":"131.e1","DOI":"10.1016\/j.ajog.2010.03.003","article-title":"Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate","volume":"203","author":"Martinez-Saguer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE23","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2010.02368.x","article-title":"Type III hereditary angio-oedema: clinical and biological features in a French cohort","volume":"65","author":"Vitrat-Hincky","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.009_bibE24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1258\/om.2009.090003","article-title":"Hereditary angioedema and pregnancy: successful management of recurrent and frequent attacks of angioedema with C1-inhibitor concentrate, danazol and tranexamic acid\u2014a case report","volume":"2","author":"Milingos","year":"2009","journal-title":"Obstet Med"},{"key":"10.1016\/j.jaip.2020.03.009_bibE25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1479-828X.2008.00945.x","article-title":"Hereditary angioedema and pregnancy","volume":"49","author":"Chinniah","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE26","first-page":"365","article-title":"Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate","volume":"54","author":"Gorman","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jaip.2020.03.009_bibE27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14767050701411851","article-title":"Hereditary angioedema and pregnancy","volume":"20","author":"Duvvur","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jaip.2020.03.009_bibE28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00404-007-0329-1","article-title":"Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report","volume":"276","author":"Hermans","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jaip.2020.03.009_bibE29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1157\/13106781","article-title":"A\u00a0successful pregnancy and uncomplicated labor with C1INH concentrate prophylaxis in a patient with hereditary angioedema","volume":"35","author":"Caliskaner","year":"2007","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2020.03.009_bibE30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2007.07778.x","article-title":"A\u00a0case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene","volume":"156","author":"Bouillet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00404-006-0183-6","article-title":"Pregnancy and C1 esterase inhibitor deficiency: a successful outcome","volume":"274","author":"Nathani","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jaip.2020.03.009_bibE32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1701-2163(16)32048-5","article-title":"Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case report","volume":"28","author":"Altman","year":"2006","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jaip.2020.03.009_bibE33","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0959-289X(99)80011-9","article-title":"Parturition and angioneurotic oedema","volume":"8","author":"Marescal","year":"1999","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.jaip.2020.03.009_bibE35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2265.2004.02009.x","article-title":"Sex hormones in hereditary angioneurotic oedema","volume":"60","author":"Visy","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaip.2020.03.009_bibE36","first-page":"54","article-title":"Life-threatening laryngeal oedema in a pregnant woman with hereditary angioedema","volume":"69","author":"McGlinchey","year":"2000","journal-title":"Ulster Med J"},{"key":"10.1016\/j.jaip.2020.03.009_bibE37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2044.1995.tb06050.x","article-title":"Hereditary angioneurotic oedema: current management in pregnancy","volume":"50","author":"Cox","year":"1995","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaip.2020.03.009_bibE38","first-page":"229p","article-title":"Cutaneous necrosis in pregnancy secondary to activated protein C resistance in hereditary angioedema","volume":"88","author":"Perkins","year":"1995","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.jaip.2020.03.009_bibE39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-0528.1988.tb06585.x","article-title":"Hereditary angioneurotic oedema and pregnancy. Case reports and review of the literature","volume":"95","author":"Chappatte","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaip.2020.03.009_bibE40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00000441-198207000-00001","article-title":"Hereditary angioedema: an appraisal of 104 cases","volume":"284","author":"Cicardi","year":"1982","journal-title":"Am J Med Sci"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820302506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820302506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:22:54Z","timestamp":1761974574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820302506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213219820302506"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.009","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}